Healthcare
Bain- and Cinven-backed Stada buys 15 GSK brands
Deal is part of Stada's growth in the consumer health and over-the-counter sectors
PE still hungry for retirement homes, but infra funds loom
Eight deals were completed in the retirement homes sector across Europe in 2019, above the annual average of five since 2014
Aksia-backed Primo invests in L Catterton's CareDent
Combined group will operate a network of 155 dental clinics and generate revenues of around €100m
Praetura leads £7m round for Inotec
Praetura is currently investing from its EIS 2020 Fund, which closed on £7m in February 2020
KKR-backed Gamma takes stake in Univercells subsidiary
KKR's $50m investment in Univercells will be drawn from its Health Care Strategic Growth Fund
Palatine sells Vernacare to HIG
HIG is currently investing from Growth Buyout Equity Fund III, which closed on $970m
Vesalius, Swisscanto in €19m series-B for OncoDNA
Fresh capital will be used for international growth and software development acceleration
Main Capital sells TPSC to PE-backed Symplr
Sale ends a six-year holding period for the GP, which bought TPSC via its €40m Main Capital III fund
DPE sells stake in PharmaZell to Bridgepoint
Deutsche Private Equity invested in the company in 2013 and began the sale process in August 2019
Amundi PEF, SGCP back Vivalto Vie in capital reshuffle
Azulis Capital exits the care home operator, having backed it since 2015
Nexxus Iberia buys Grupo Bienzobas
Fifth investment made by the GP via its first Spanish fund, Nexxus Iberia Private Equity Fund I
Fountain Healthcare invests €5m in Inotrem
In addition, Inotrem receives a €13m credit line from Kreos Capital and a €1m loan from BPI France
Forbion leads €25m series-A for Azafaros
Fresh capital will be used to expand the company's executive team and strengthen the organisation
Cerberus sells Covis Pharma to Apollo
Sale ends a nine-year holding period for the GP, which built Covis through a series of acquisitions
Consortium in CHF 23m series-C for Lunaphore
Fresh capital will be used for market and product expansion in the US and Europe
PVP fully acquires Avenir Medical Poland
In May 2018, PVP acquired an initial 56% stake in AMP from the company's founders
Management retains control of Ceva Santé Animale in 5th buyout
Historic transaction is one of the largest-ever French LBOs, and the largest ever led by a management team
Ergon-backed Opseo buys ZBI NRW
Regional group was previously part of ZBI and will open new clinics in North Rhine-Westphalia
ICG transfers Esperi ownership to lenders
Esperi will be owned by a new parent company controlled by Danske Bank, Ilmarinen and SEB
GHO backs Portuguese biotech company FairJourney
GP invests from its GHO Capital Fund II, which held a final close on its €975m hard-cap in November 2019
Triton's Meine Radiologie buys Strahlentherapie Augsburg
Triton invested in the radiotherapy provider in 2019 and the company has since bought several clinics
MTIP et al. exit Blueprint Genetics to trade
Listed, US-based diagnostic information service Quest Diagnostics has acquired Blueprint
VCs in €20m series-B for PDCLine
In 2016, Belgian VC Meusinvest, Spinventure and several business angels invested €4m in the company
Telemos-backed MedEuropa buys CCO
Ardian provides debt for the acquisition of the France-based cancer treatment centre